TGFB1 Antikörper (C-Term)
Kurzübersicht für TGFB1 Antikörper (C-Term) (ABIN7185599)
Target
Alle TGFB1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- C-Term
-
Kreuzreaktivität
- Human, Maus, Ratte
-
Aufreinigung
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
-
Immunogen
- Synthesized peptide derived from the C-terminal region of Human TGFbeta1.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- WB:1:500-1:2000, IHC:1:100-1:300, IF:1:200-1:1000, ELISA:1:20000,
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Liquid in PBS containing 50 % glycerol, 0.5 % BSA and 0.02 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- TGFB1 (Transforming Growth Factor, beta 1 (TGFB1))
-
Andere Bezeichnung
- TGFB1
-
Hintergrund
- Cartilage-inducing factor antibody, CED antibody, Differentiation inhibiting factor antibody, DPD1 antibody, LAP antibody, Latency-associated peptide antibody, Prepro transforming growth factor beta 1 antibody, TGF beta 1 antibody, TGF beta antibody, TGF beta 1 protein antibody, TGF-beta 1 protein antibody, TGF-beta-1 antibody, TGF-beta-5 antibody, TGF-beta1 antibody, TGFB antibody, Tgfb-1 antibody, tgfb1 antibody, TGFB1_HUMAN antibody, TGFbeta antibody, TGFbeta1 antibody, Transforming Growth Factor b1 antibody, Transforming Growth Factor beta 1 antibody, Transforming growth factor beta 1a antibody, transforming growth factor beta-1 antibody, transforming growth factor, beta 1 antibody, Transforming Growth Factor-1 antibody
-
UniProt
- P01137
-
Pathways
- EGFR Signaling Pathway, Dopaminergic Neurogenesis, Cellular Response to Molecule of Bacterial Origin, Glycosaminoglycan Metabolic Process, Regulation of Leukocyte Mediated Immunity, Regulation of Muscle Cell Differentiation, Positive Regulation of Immune Effector Process, Cell-Cell Junction Organization, Production of Molecular Mediator of Immune Response, Ribonucleoside Biosynthetic Process, Skeletal Muscle Fiber Development, Regulation of Carbohydrate Metabolic Process, Protein targeting to Nucleus, Autophagie, Cancer Immune Checkpoints
Target
-